These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2663197)

  • 1. DNA alkylation and formation of DNA interstrand cross-links by potential antitumour 2,5-bis(1-aziridinyl)-1,4-benzoquinones.
    Lusthof KJ; De Mol NJ; Janssen LH; Verboom W; Reinhoudt DN
    Chem Biol Interact; 1989; 70(3-4):249-62. PubMed ID: 2663197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent binding studies on the 14C-labeled antitumor compound 2,5-bis(1-aziridinyl)-1,4-benzoquinone. Involvement of semiquinone radical in binding to DNA, and binding to proteins and bacterial macromolecules in situ.
    Lusthof KJ; De Mol NJ; Janssen LH; Egberink RJ; Verboom W; Reinhoudt DN
    Chem Biol Interact; 1990; 76(2):193-209. PubMed ID: 1699678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-DNA interstrand cross-linking by 2,5-bis(1-aziridinyl)-3,6-bis(carbethoxyamino)-1,4-benzoquinone: covalent structure of the dG-to-dG cross-links in calf thymus DNA and a synthetic DNA duplex.
    Alley SC; Hopkins PB
    Chem Res Toxicol; 1994; 7(5):666-72. PubMed ID: 7841346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential anti-tumour 2,5-bis (1-aziridinyl)-1,4-benzoquinones: relationship between cytotoxicity against DNA-repair deficient E. coli, inactivation of bacteriophage M13mp19, and in vitro and in vivo anti-tumour activity.
    Lusthof KJ; Groothuis-Pielage IL; Decuyper J; de Mol NJ; Janssen LH; Verboom W; Reinhoudt DN
    Anticancer Drug Des; 1988 Dec; 3(3):147-55. PubMed ID: 3061386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration in DNA cross-linking and sequence selectivity of a series of aziridinylbenzoquinones after enzymatic reduction by DT-diaphorase.
    Lee CS; Hartley JA; Berardini MD; Butler J; Siegel D; Ross D; Gibson NW
    Biochemistry; 1992 Mar; 31(11):3019-25. PubMed ID: 1372518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkylation of DNA by the new anticancer agent 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone (AZQ).
    King CL; Wong SK; Loo TL
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):261-4. PubMed ID: 6538490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alkylation of DNA in vitro by 2,5-bis(2-hydroxyethylamino)-3,6-diaziridinyl-1,4-benzoquinone (BZQ)--I.
    Butler J; Hoey BM; Ward TH
    Biochem Pharmacol; 1989 Mar; 38(6):923-7. PubMed ID: 2930592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between potential anti-tumour 2,5-bis(1-aziridinyl)-1,4-benzoquinone derivatives and glutathione: reductive activation, conjugation and DNA damage.
    Lusthof KJ; de Mol NJ; Janssen LH; Prins B; Verboom W; Reinhoudt DN
    Anticancer Drug Des; 1990 Aug; 5(3):283-90. PubMed ID: 2205226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of DNA strand breakage and interstrand cross-linking by diaziridinylbenzoquinone (diaziquone) in isolated nuclei from human cells.
    Szmigiero L; Kohn KW
    Cancer Res; 1984 Oct; 44(10):4453-7. PubMed ID: 6467205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemistry and DNA alkylation reactions of aziridinyl quinones: development of an efficient alkylating agent of the phosphate backbone.
    Skibo EB; Xing C
    Biochemistry; 1998 Oct; 37(43):15199-213. PubMed ID: 9790684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA cross-linking and sequence selectivity of aziridinylbenzoquinones: a unique reaction at 5'-GC-3' sequences with 2,5-diaziridinyl-1,4-benzoquinone upon reduction.
    Hartley JA; Berardini M; Ponti M; Gibson NW; Thompson AS; Thurston DE; Hoey BM; Butler J
    Biochemistry; 1991 Dec; 30(50):11719-24. PubMed ID: 1751490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-linking and sequence specific alkylation of DNA BY aziridinylquinones. 1. Quinone methides.
    Mayalarp SP; Hargreaves RH; Butler J; O'Hare CC; Hartley JA
    J Med Chem; 1996 Jan; 39(2):531-7. PubMed ID: 8558523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemical reduction of diaziquone: products and free radical intermediates.
    Gutierrez PL; Balachandran Nayar MS; Nardino R; Callery PS
    Chem Biol Interact; 1987; 64(1-2):23-37. PubMed ID: 2826025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lack of correlation between toxicity and free radical formation of two diaziridinyl benzoquinones.
    Lea JS; Garner HJ; Butler J; Hoey BM; Ward TH
    Biochem Pharmacol; 1988 May; 37(10):2023-5. PubMed ID: 2837220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA strand scission and cross-linking by diaziridinylbenzoquinone (diaziquone) in human cells and relation to cell killing.
    Szmigiero L; Erickson LC; Ewig RA; Kohn KW
    Cancer Res; 1984 Oct; 44(10):4447-52. PubMed ID: 6467204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CB 1954 (2,4-dinitro-5-aziridinyl benzamide) becomes a DNA interstrand crosslinking agent in Walker tumour cells.
    Roberts JJ; Friedlos F; Knox RJ
    Biochem Biophys Res Commun; 1986 Nov; 140(3):1073-8. PubMed ID: 3778483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different type of DNA damage caused by three aziridinyl substituted cyclophosphazenes in a human small cell lung carcinoma cell line.
    Zijlstra JG; de Jong S; van de Grampel JC; de Vries EG; Mulder NH
    Cancer Res; 1986 Jun; 46(6):2726-9. PubMed ID: 3008999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism(s) of bioreductive activation. The example of diaziquone (AZQ).
    Gutierrez PL
    Free Radic Biol Med; 1989; 6(4):405-45. PubMed ID: 2651223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-linking and sequence specific alkylation of DNA by aziridinyl quinones. 2. Structure requirements for sequence selectivity.
    Hargreaves RH; Mayalarp SP; Butler J; McAdam SR; O'Hare CC; Hartley JA
    J Med Chem; 1997 Jan; 40(3):357-61. PubMed ID: 9022802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reductive activation of potential antitumor bis(aziridinyl)benzoquinones by xanthine oxidase: competition between oxygen reduction and quinone reduction.
    Lusthof KJ; Richter W; de Mol NJ; Janssen LH; Verboom W; Reinhoudt DN
    Arch Biochem Biophys; 1990 Feb; 277(1):137-42. PubMed ID: 2154955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.